Prof. Dr. Anja Katrin Boßerhoff

Lehrstuhl für Biochemie und Molekulare Medizin

Clinicopathologic overview of melanoma (2017) Boßerhoff AK, Strizzi L Authored book MiRNAs in malignant melanoma (2017) Mione M, Liebig J, Munoz L, Boßerhoff AK Authored book UVB radiation represses CYLD expression in melanocytes (2017) Kuphal S, Schneider N, Massoumi R, Hellerbrand C, Boßerhoff AK Journal article Can checkpoint inhibitor therapy improve response to chemotherapy? (2017) Boßerhoff AK, Schuler G, Heinzerling L, Schilling B, Haferrkamp S, Kirchberger M Conference contribution, Conference Contribution Effect of melanoma cells on proliferation and migration of activated hepatic stellate cells in vitro (2017) Meyer T, Koch A, Ebert EV, Czech B, Mueller M, Boßerhoff AK, Lang SA, Hellerbrand C Journal article Investigation of toxicity and mutagenicity of cold atmospheric argon plasma (2017) Maisch T, Boßerhoff AK, Unger P, Heider J, Shimizu T, Zimmermann JL, Morfill GE, et al. Journal article Cold atmospheric plasma (CAP) activates angiogenesis-related molecules in skin keratinocytes, fibroblasts and endothelial cells and improves wound angiogenesis in an autocrine and paracrine mode (2017) Arndt S, Unger P, Berneburg M, Boßerhoff AK, Karrer S Journal article Usability and Suitability of the Omics-Integrating Analysis Platform tranSMART for Translational Research and Education (2017) Christoph J, Knell C, Boßerhoff AK, Naschberger E, Stürzl M, Rübner M, Seuß H, et al. Journal article Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells (2017) Uslu U, Schliep S, Schliep K, Erdmann M, Koch HU, Parsch H, Rosenheinrich S, et al. Journal article Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition (2017) Dietrich P, Kuphal S, Spruss T, Hellerbrand C, Boßerhoff AK Journal article